US Patent Issued to INSERM (INSTITUTE NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE), Universite de Lille, Instiut Pasteur de Lille, Centre Hospitalier Regional Universitaire de Lille on March 31 for "Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve" (French Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,189, issued on March 31, was assigned to INSERM (INSTITUTE NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE) (Paris), Universite de Lille (Lille, France), Instiut Pasteur de Lille (Lille, France) and Centre Hospitalier Regional Universitaire de Lille (Lille, France).

"Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve" was invented by Sophie Susen (Lille, France), Delphine Corseaux (Lille, France), Yoann Sottejeau (Lille, France), Mickael Rosa (Lille, France), Jerome Soquet (Lille, France), Eric Van Belle (Lille, France), Bart Staels (Lille, France) and Annabelle Dupont (Lille, France).

According to the abstract* rel...